|
MTA3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.775000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.422150E-01 |
| Normal-vs-Stage2 |
7.446000E-01 |
| Normal-vs-Stage3 |
1.691620E-01 |
| Normal-vs-Stage4 |
7.681600E-01 |
| Stage1-vs-Stage2 |
2.302600E-01 |
| Stage1-vs-Stage3 |
1.083790E-02 |
| Stage1-vs-Stage4 |
5.211400E-01 |
| Stage2-vs-Stage3 |
4.124800E-01 |
| Stage2-vs-Stage4 |
8.795000E-01 |
| Stage3-vs-Stage4 |
7.323000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.364200E-01 |
| Normal-vs-AfricanAmerican |
5.636000E-01 |
| Normal-vs-Asian |
3.737000E-01 |
| Caucasian-vs-AfricanAmerican |
8.236600E-01 |
| Caucasian-vs-Asian |
2.425400E-01 |
| AfricanAmerican-vs-Asian |
1.997630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.582300E-02 |
| Normal-vs-Female |
1.699660E-02 |
| Male-vs-Female |
2.32879999999547E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.734800E-01 |
| Normal-vs-Extreme_Weight |
3.981900E-02 |
| Normal-vs-Obese |
8.040800E-01 |
| Normal-vs-Extreme_Obese |
8.755400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.380240E-01 |
| Normal_Weight-vs-Obese |
7.329000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.077000E-01 |
| Extreme_Weight-vs-Obese |
5.163700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.418600E-01 |
| Obese-vs-Extreme_Obese |
9.638800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.967800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.091600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.304590E-01 |
| Normal-vs-Age(81-100Yrs) |
2.482100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.456300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.149500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.517100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.974400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.371530E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.702620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.549170E-01 |
| Normal-VS-Type2 PRCC |
2.375400E-01 |
| Normal-VS-KIRP CIMP |
2.532200E-02 |
| Normal-VS-Unclassified PRCC |
2.945400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.073000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.79700000000538E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
6.193700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.084930E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.070100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.152200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.012240E-01 |
| Normal-vs-N1 |
2.240000E-02 |
| Normal-vs-N2 |
2.423200E-01 |
| N0-vs-N1 |
3.540400E-03 |
| N0-vs-N2 |
1.590610E-01 |
| N1-vs-N2 |
6.088400E-01 |
|
|
